Abstract
The paper summarizes the results of research into the effect on haemopoiesis of transplantation of allogenic bone marrow into dogs suffering from depressed haemopoiesis caused by ionizing radiation and a chemical agent (myelosan). Myelotherapy was carried out with the ganglion-blocking agent gangleron (synthesized by the Fine Organic Chemistry Institute of the Armenian Academy of Sciences) and prednisolone. This method of therapy has prevented the development of secondary disease and contributed to a high survival rate. (author)
Antonyan, K. A.
[1]
- Armenian Institute of Haematology and Blood Transfusion, Yerevan, USSR (Armenia)
Citation Formats
Antonyan, K. A.
Suppression of Immunogenesis When Using Gangleron and Prednisolone.
IAEA: N. p.,
1969.
Web.
Antonyan, K. A.
Suppression of Immunogenesis When Using Gangleron and Prednisolone.
IAEA.
Antonyan, K. A.
1969.
"Suppression of Immunogenesis When Using Gangleron and Prednisolone."
IAEA.
@misc{etde_22192472,
title = {Suppression of Immunogenesis When Using Gangleron and Prednisolone}
author = {Antonyan, K. A.}
abstractNote = {The paper summarizes the results of research into the effect on haemopoiesis of transplantation of allogenic bone marrow into dogs suffering from depressed haemopoiesis caused by ionizing radiation and a chemical agent (myelosan). Myelotherapy was carried out with the ganglion-blocking agent gangleron (synthesized by the Fine Organic Chemistry Institute of the Armenian Academy of Sciences) and prednisolone. This method of therapy has prevented the development of secondary disease and contributed to a high survival rate. (author)}
place = {IAEA}
year = {1969}
month = {Jul}
}
title = {Suppression of Immunogenesis When Using Gangleron and Prednisolone}
author = {Antonyan, K. A.}
abstractNote = {The paper summarizes the results of research into the effect on haemopoiesis of transplantation of allogenic bone marrow into dogs suffering from depressed haemopoiesis caused by ionizing radiation and a chemical agent (myelosan). Myelotherapy was carried out with the ganglion-blocking agent gangleron (synthesized by the Fine Organic Chemistry Institute of the Armenian Academy of Sciences) and prednisolone. This method of therapy has prevented the development of secondary disease and contributed to a high survival rate. (author)}
place = {IAEA}
year = {1969}
month = {Jul}
}